Testing effectiveness (Phase 2)Study completedNCT04622592
What this trial is testing
Adjuvanted Seasonal Recombinant Quadrivalent Virus-Like Particles (QVLP) Influenza Vaccine in Adults 65 Years of Age and Older
Who this might be right for
Influenza
Medicago 209